Demand for architectural design services continued to decline in June, with the Architecture Billings Index slipping to 46.8 ...

UBS Group AG has ended a multimillion dollar contract with BlackRock Inc.’s Aladdin technology platform that it inherited ...

Investing.com -- UBS has initiated coverage on Ionos with a “buy” rating and a 12-month price target of €47, citing ...

Due to strong hedge fund interest, Freeport-McMoRan Inc. (NYSE:FCX) is among the 11 Best Mineral Stocks to Buy According to ...

UBS Group AG is reviewing the role of six relationship managers who sold complex currency derivatives to Swiss clients who ...

UBS sees Mosaic ( MOS) as a beneficiary of rising potash prices, which have climbed from approximately $280a metric ton at ...

Oscar's strong revenue growth, improving profitability, and efficient SG&A management support my positive outlook. Read why ...

Merck & Co., Inc. (NYSE:MRK) ranks among the best magic formula stocks to invest in. On July 10, UBS reiterated its Buy ...

Incyte Corporation (NASDAQ:INCY) is one of the best biotech stocks to buy according to billionaire Steve Cohen.

A former managing director for UBS' wealth management business in Silicon Valley is no longer with the firm after allegations ...

A survey of central bank reserve managers commissioned by UBS finds that nearly half thinks the unthinkable — that the U.S. restructuring its debt is a “plausible” scenario.

Investing.com -- UBS is maintaining a neutral stance on U.K. equities while recommending selective exposure due to near-term growth uncertainty and currency headwinds for corporate profits.